Background: The ability to discriminate very similar objects by implementing the binding between their multiple features is assumed to be supported by the medial temporal lobe (MTL). MTL is the first brain region that shows abnormal tau accumulation in Alzheimer's disease (AD). However, whether binding ability is impaired since the preclinical stage of AD and relates to MTL tau burden is not well-established.

Method: We included 35 amyloid-negative cognitively normal individuals (Aβ-CN), 16 amyloid-positive CN (Aβ+CN) and 17 Aβ+ individuals with Mild Cognitive Impairment (Aβ+MCI). Aβ status was determined using lumbar punction or [F]-Flutemetamol Positron Emission Tomography (PET). Participants underwent a [F]-MK6240 tau-PET to quantify tau burden in the MTL (entorhinal cortex, hippocampus, parahippocampus). They performed the Visual-Short-Term-Memory-Binding-Test (VSTMBT), a test which is underpinned by the proper functioning of the MTL (Parra et al., 2010) and assess the ability to discriminate perceptually close items. In VSTMBT, participants had to determine whether a set of shapes was identical to the set presented before a 900ms blank retention interval. There were 4 conditions in which the number of shapes (2 or 3) and the color (white = "Shape-Only Condition" or colored) of the shapes varied. The colored conditions implied to memorize the binding between shapes and their respective color ("Binding-Condition")(Figure.1). We calculated the accuracy score (AS) and the mean reaction time (RT) for each condition.

Result: AS was lower in both Aβ+ groups than in Aβ-CN participants in all conditions except the Shape-Only-2-items, while Aβ+CN and Aβ+MCI did not differ (Figure.2). The Aβ+CN group was slower than Aβ-CN only in the Binding-2-items-Condition. Total AS was associated with MTL tauopathy over the entire sample (even after controlling for age and education) and when restricting to all CN participants. Finally, MTL tauopathy was more associated to AS in the Binding-Condition than in the Shape-Only-Condition (Figure.3).

Conclusion: Impaired visual short-term memory performance was evidenced since the preclinical stage of AD, including in Binding-Condition. Performance in Binding-Condition was related to tau burden in the MTL, suggesting that impairment in visual short-term memory binding abilities may constitute an early cognitive marker of accumulating tau pathology in the MTL.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.086401DOI Listing

Publication Analysis

Top Keywords

tau burden
12
mtl
9
ability discriminate
8
preclinical stage
8
burden mtl
8
mtl tauopathy
8
visual short-term
8
short-term memory
8
tau
5
clinical manifestations
4

Similar Publications

Changes in brain mitochondrial metabolism are coincident with functional decline; however, direct links between the two have not been established. Here, we show that mitochondrial targeting via the adiponectin receptor activator AdipoRon (AR) clears neurofibrillary tangles (NFTs) and rescues neuronal tauopathy-associated defects. AR reduced levels of phospho-tau and lowered NFT burden by a mechanism involving the energy-sensing kinase AMPK and the growth-sensing kinase GSK3b.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Laboratory for Neuropathology, KU Leuven, Leuven, Belgium.

Background: In 43-63% of symptomatic Alzheimer's disease (AD) patients, there is an observed accumulation of misfolded alpha-synuclein (αSyn). Two primary αSyn subtypes have been identified based on the underlying spreading pattern of this pathology: caudo-rostral and amygdala-predominant. Interactions between pathological TDP-43, Tau, and αSyn can aggravate their spread and aggregation.

View Article and Find Full Text PDF

Background: Sleep dysfunction is commonly seen in Alzheimer's disease (AD) and Progressive Supranuclear Palsy (PSP), potentially worsening these conditions. Investigating early neuropathological changes in human sleep-promoting neurons, which often precede cognitive decline, is crucial for understanding the basis for sleep dysfunction as possible treatments yet remain underexplored. We used postmortem brains of AD and PSP patients to quantify neuronal numbers and tau burden in the intermediate nucleus of the hypothalamus (IntN), VLPO analog, known for its role in sleep maintenance.

View Article and Find Full Text PDF

Motor proteins play a key role in neuronal functions and morphology that are important for learning and memory. We have previously reported that increased expression KIF11/Kinesin-5 overrides Aß-mediated effects on dendritic spine density and long-term potentiation in a mouse model of Alzheimer's disease (AD), effectively maintaining cognitive function in the face of Aß pathology. Here, we evaluated the association of key AD phenotypes with mRNA expression levels of a select set of Dynein motor proteins METHOD: We utilized measurements of gene expression, AD neuropathology burden, and cognition provided by the ROS/MAP study to determine whether an association exists between AD phenotypes and expression of genes for cytoplasmic and axonemal dynein heavy chains.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Background: Microglia undergo varying regional dependent functional changes, which can exacerbate cognitive decline in Alzheimer's disease, but the full clinical relevance remains unclear. Ramified microglia survey the micro-environment and inert/amoeboid microglia engulf debris. A third morphological type; rod microglia, have been observed in a number of pathological conditions, but are relatively understudied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!